-
-
-
-
-
-
-
Biologics Market Momentum Accelerates Across Healthcare, AI, And Global Medical Tourism
-
-
-
-
-
-
-
Regeneron (REGN) Tops Q4 EPS by 92c
-
-
-
-
-
-
-
EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension
-
-
-
-
-
-
-
Regeneron shares slide on mixed trial data for smoker's lung drug
-
-
-
-
-
-
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
-
-
-
-
-
-
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
-
-
-
-
-
-
-
Regeneron (REGN) Tops Q4 EPS by 80c
-
1,227,473 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

